Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: Efficacy and risk of fungal over-infection

Oral Diseases

Volumn 12, Issue 6, 2006, Pages 559-565

  Gonzalez Garcia A ^a,b   Diniz Freitas, M ^a   Gandara Vila P ^a   Blanco Carrion A ^a   Garcia Garcia A ^a   Gandara Rey J M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Fungal infections; Oral lichen planus; Topical corticoids; Triamcinolone

Indexed keywords

CHLORHEXIDINE GLUCONATE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFECTION RISK; LICHEN PLANUS; MALE; MEDICAL RECORD; MOUTH HYGIENE; MYCOSIS; PRIORITY JOURNAL; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUPERINFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; CANDIDIASIS, ORAL; FEMALE; GLUCOCORTICOIDS; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTHWASHES; RETROSPECTIVE STUDIES; SUPERINFECTION; TRIAMCINOLONE ACETONIDE;

EID: 33750314114     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01238.x     Document Type: Review

References (48)

1. Aguirre JM, Bagán JV, Rodríguez C et al (2004). Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study. J Oral Pathol Med 33: 381-385.
2. Anil S, Ellepola AN, Samaranayake LP (2001). The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans. Oral Dis 7: 119-122.
3. Bagán-Sebastian JV, Milian-Manaset MA, Peñarrocha-Diago M, Jimenez Y (1992). A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg 50: 116-118.
4. Buajeeb W, Kraivaphan P, Pobrurksa C (1997). Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 21-25.
5. Camisa C, Hamaty FG, Gay JD (1998). Squamous cell carcinoma of the tongue arising in lichen planus: a case report and review of the literature. Cutis 62: 175-178.
6. Campisi G, Giandalia G, de Caro V, di Liberto C, Aricò P, Giannola LI (2004). A new delivery system of clobetasol-17 propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. Phase V, randomized, observer-blinded, parallel group clinical trial. Br J Dermatol 150: 984-990.
7. Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C (1999). Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5: 44-49.
8. Carrozzo M, Gandolfo S (1999). The management of oral lichen planus. Oral Dis 5: 181-182.
9. Chainani-Wu N, Silverman S Jr, Lozada-Nur F, Mayer P, Watson JJ (2001). Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 132: 901-909.
10. Chan ES-Y, Thornhill M, Zakrzewska J (2000). Interventions for treating oral lichen planus. Cochrane Database Syst Rev CD001168.
11. Eisen D (1993). The therapy of oral lichen planus. Crit Rev Oral Biol Med 4: 141-158.
12. Ellepola AN, Samaranayake LP (2001a). Inhalation and topical steroids, and oral candidiosis: a mini review. Oral Dis 7: 211-216.
13. Ellepola AN, Samaranayake LP (2001b). Adjunctive use of chlorhexidine in oral candidoses: a mini-review. Oral Dis 7: 11-17.
14. Epstein JB (2003). Oral lichen planus: progress in understanding its malignant potential and implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 32-37.
15. Epstein JB, Truelove EL (1996). Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol 82: 532-536.
16. Ferguson MM, Simpson NB, Hammersly N (1984). The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg Oral Med Oral Pathol 58: 283-287.
17. Gándara-Rey JM, Diniz-Freitas M, Gándara-Vila P, Blanco-Canión A, Suález-Peñarauda JM, García- García A (2004). Malignant transformation of oral lichen planus in lingual location: report of a case. Oral Oncol 40: 1-4.
18. González-Moles MA, Scully C (2005a). Vesiculo-erosive oral mucosal disease - management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future. J Dent Res 84: 302-308.
19. González-Moles MA, Scully C (2005b). Vesiculo-erosive oral mucosal disease - management with topical corticosteroids: (1) Fundamental principles and specific agents available. J Dent Res 84: 294-301.
20. González-Moles MA, Morales P, Rodríguez-Archilla A, Isabel IR, González-Moles S (2002). Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 264-270.
21. González-Moles MA, Ruiz-Ávila I, Rodríguez-Archilla A et al (2003). Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 688-692.
22. Gorsky M, Raviv M (1992). Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol 73: 52-55.
23. Holmstrup P, Schiotz AW, Westergaard J (1990). Effect of dental plaque control on gingival lichen planus. Oral Surg Oral Med Oral Pathol 69: 585-590.
24. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005). Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 164-178.
25. Lozada-Nur F, Miranda C (1997a). Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin Cutan Med Surg 16: 273-277.
26. Lozada-Nur F, Miranda C (1997b). Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg 16: 295-300.
27. Lozada-Nur F, Zhong Huang M (1991). Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 71: 293-297.
28. van der Meij EH, Schepman KP, van der Waal I (2003). The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 164-171.
29. Miller CS, Epstein JB, Hall EH, Sirois D (2001). Changing oral care needs in the United States: the continuing need for oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 34-44.
30. Nicolazzo JA, Reed BL, Finnin BC (2005). Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 105: 240-248.
31. Pacor ML, Biasi D, Urbani G, Lombardo G, Lunardi C (1994). The efficacy of cyclosporine for topical use in oral lichen planus. Minerva Stomatol 43: 129-132.
32. Pindborg JJ, Reichart PA, Smith CJ, Sobin LH (1997). WHO International Histological Classification of Tumors: Histological Typing of Cancer and Precancer of the Oral Mucosa. Springer: Berlin.
33. Plemons JM, Rees TD, Zachariah NY (1990). Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol 69: 688-693.
34. Pogrel MA, Weldon LL (1983). Carcinoma arising in erosive lichen planus in the midline of the dorsum of the tongue. Oral Surg Oral Med Oral Pathol 55: 62-66.
35. Porter SR, Scully C, Eveson JW (1993). The efficacy of topical cyclosporine in the management of desquamative gingivitis due to lichen planus. Br J Dermatol 129: 753-755.
36. Ramon-Fluixa C, Bagan-Sebastian J, Milian-Masanet M, Scully C (1999). Periodontal status in patients with oral lichen planus: a study of 90 cases. Oral Dis 5: 303-306.
37. Regezi JA, Ellis CN, Stewart JC, Giustina TA (1986). Histological changes associated with the topical use of isotretinoin on oral lichen planus. Oral Surg Oral Med Oral Pathol 61: 479-484.
38. Schacke H, Docke WD, Asadullah K (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96: 23-43.
39. Scully C, Beyli M, Ferreiro MC et al. (1998). Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9: 86-122.
40. Sieg P, Von Domarus H, Von Zitzewitz V, Iven H, Farber L (1995). Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br J Dermatol 132: 790-794.
41. Silverman S Jr (2000). Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 58: 1286-1288.
42. Silverman S Jr, Gorsky M, Lozada-Nur F, Giannotti K (1991). A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 72: 665-670.
43. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W (1992). Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 21: 456-458.
44. Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C (2003). Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 32: 315-322.
45. Ungphaiboom S, Maitani Y (2001). In vitro permeation studies of triamcinolone acetonide mouthwashes. Int J Pharm 220: 111-117.
46. Vincent SD, Fotos PG, Baker KA, Williams TP (1990). Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 70: 165-171.
47. Walsh P, Aeling JL, Huff L, Weston WL (1993). Hypothalamus-pituitary- adrenal axis suppression by superpotent topical steroids. J Am Acad Dermatol 29: 501-503.
48. WHO Collaborating Centre for Oral Precancerous Lesions (1978). Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46: 518-539.